Innovation1 Financial Statements From 2010 to 2024
| IVBT Stock | USD 0 0.00 0.00% |
Check Innovation1 Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Innovation1 Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Innovation1 financial statements analysis is a perfect complement when working with Innovation1 Biotech Valuation or Volatility modules.
Innovation1 |
Innovation1 Biotech OTC Stock Current Valuation Analysis
Innovation1 Biotech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Innovation1 Biotech Current Valuation | 1.83 M |
Most of Innovation1 Biotech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Innovation1 Biotech is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Innovation1 Biotech has a Current Valuation of 1.83 M. This is 99.99% lower than that of the Healthcare sector and 99.96% lower than that of the Biotechnology industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
Innovation1 Biotech Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Innovation1 Biotech's current stock value. Our valuation model uses many indicators to compare Innovation1 Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Innovation1 Biotech competition to find correlations between indicators driving Innovation1 Biotech's intrinsic value. More Info.Innovation1 Biotech is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Innovation1 Biotech's earnings, one of the primary drivers of an investment's value.About Innovation1 Biotech Financial Statements
Innovation1 Biotech shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Innovation1 Biotech investors may analyze each financial statement separately, they are all interrelated. The changes in Innovation1 Biotech's assets and liabilities, for example, are also reflected in the revenues and expenses on on Innovation1 Biotech's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Innovation1 Biotech Inc. operates as a small molecule drug discovery company. The company was founded in 2014 and is based in New York, New York. Innovation1 Biotech operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 1 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Innovation1 OTC Stock Analysis
When running Innovation1 Biotech's price analysis, check to measure Innovation1 Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation1 Biotech is operating at the current time. Most of Innovation1 Biotech's value examination focuses on studying past and present price action to predict the probability of Innovation1 Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation1 Biotech's price. Additionally, you may evaluate how the addition of Innovation1 Biotech to your portfolios can decrease your overall portfolio volatility.